4//SEC Filing
Bratica Joseph 4
Accession 0001209191-20-062807
CIK 0000873303other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:23 PM ET
Size
9.2 KB
Accession
0001209191-20-062807
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-08$29.60/sh+1,125$33,300→ 9,265 total - Sale
Common Stock
2020-12-08$160.00/sh−1,125$180,000→ 8,140 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-08−1,125→ 4,500 totalExercise: $29.60From: 2018-03-31Exp: 2027-03-31→ Common Stock (1,125 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
- [F2]Amount of Securities Beneficially Owned includes 308 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2020.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001820070
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:23 PM ET
- Size
- 9.2 KB